Targeting epidermal growth factor receptor for head and neck squamous cell carcinoma: still lost in translation?

Chapman, Christopher H; Saba, Nabil F; Yom, Sue S

Chapman, Christopher H; Saba, Nabil F; Yom, Sue S.

Afiliación

Chapman CH; 1 Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA ; 2 Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
Saba NF; 1 Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA ; 2 Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
Yom SS; 1 Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA ; 2 Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.

Ann Transl Med ; 4(4): 80, 2016 Feb.

Article en En | MEDLINE | ID: mdl-27004227

Palabras clave

Epidermal growth factor receptor (EGFR); head and neck cancer; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Ann Transl Med Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google